DOCUMENT DRAWER
The FDA has added brucellosis, as well as opisthorchiasis and paragonimiasis, to the list of designated tropical diseases whose product applications may result in the award of priority review vouchers.
Sen. Steve Daines (R-Mont.), in a letter to McConnell and Minority Leader Chuck Schumer, called for more funding on the development and manufacturing of Covid-19 vaccines and drugs in the next coronavirus relief package.
The FDA will have a public advisory committee meeting of the Science Advisory Board to the National Center for Toxicological Research on Aug. 18-19.
The Presidential Advisory Council on HIV/AIDS will hold a council meeting virtually on Aug. 6 to discuss Covid-19 and HIV, and Ready, Set, PrEP enrollment.
Thermo Fisher Scientific and Qiagen N.V. are amending their acquisition agreement, increasing the offer price for Qiagen shares.
Patrizia Cavazzoni, the acting director of FDA’s Center for Drug Evaluation and Research, and Anand Shah, deputy commissioner for FDA’s Medical and Scientific Affairs, discussed clinical trials and treatments for Covid-19.